Table 1.
Clinical characteristics of women with DOR (cases) and a control group (controls)
| Cases | Controls | |
|---|---|---|
| Cohort,n | 20 | 100 |
| Age (years) | ||
| Median (range) | 38.3 (30.8–39.8) | 29.9 (2.8–42.7) |
| Diagnoses (%) | ||
| Breast cancer | – | 39 |
| Cervical cancer | – | 6 |
| Diminished ovarian reserve | 100 | – |
| Hodgkin/non-hodgkin disease | – | 20 |
| Sarcoma | – | 13 |
| Others | – | 22 |
| Follicle density (follicles per mm3 tissue) | ||
| Median (range) | 1.9 (0–93.7) | 16.3 (0–1578) |
| Cohort,n | 20 | 35 |
| AMH (pmol/L) | ||
| Median (range) | 1.9 (0.21–5.2*) | 14.4 (2.7–50.4) |
| FSH (IU/L) | ||
| Median (range) | 10.4 (4.8–25.9) | NA |
| AFC | ||
| Median (range) | 5 (2–9) | NA |
| Cohort,n | 20 | 78 |
| Ovarian volume (mL) (n) | ||
| Median (range) | 3.96 (1.77–10.22) | 5.87 (0.5–15.10) |
DOR diminished ovarian reserve, AMH anti-Müllerian hormone, FSH follicle-stimulating hormone, AFC antral follicle count
*One patient with DOR had a single AMH level of 5.2 pmol/L before the laparoscopy